Medrol

Methylprednisolone, the active ingredient in Medrol, is a corticosteroid presented as an oral tablet for systemic use. It reduces inflammation and suppresses immune responses in a variety of acute and chronic conditions. GNH USA supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylprednisolone acts as a potent anti‑inflammatory and immunosuppressive agent across several disease families. - Asthma exacerbations: rapid reduction of airway inflammation and improvement of breathing. - Rheumatoid arthritis: alleviation of joint swelling, pain and stiffness. - Systemic lupus erythematosus: control of systemic inflammation and organ involvement. - Allergic reactions: mitigation of severe allergic symptoms such as angio‑edema. - Inflammatory bowel disease: induction of remission in ulcerative colitis and Crohn’s disease flares.

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased appetite and weight gain - Insomnia or difficulty sleeping - Mood swings or irritability - Elevated blood glucose levels - Gastrointestinal discomfort or ulcer risk - Fluid retention and mild edema

Serious or Rare Side Effects: - Adrenal insufficiency on abrupt discontinuation - Severe infections due to immunosuppression - Osteoporosis and increased fracture risk - Psychosis or severe mood disorders - Cushingoid appearance with prolonged use - Hyperkalemia or severe electrolyte disturbances

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications. - Infection risk: assess for active infections and avoid initiating therapy in uncontrolled sepsis. - Blood glucose: monitor diabetic patients closely for hyperglycaemia. - Bone health: consider baseline bone density assessment for long‑term use. - Tapering: discontinue gradually to prevent adrenal crisis. - Hypersensitivity: avoid in patients with known allergy to methylprednisolone or excipients. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methylprednisolone can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Ketoconazole and other strong CYP3A4 inhibitors: may increase steroid levels. - Rifampin or other CYP3A4 inducers: may reduce efficacy. - Live vaccines: risk of attenuated infection. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect. - NSAIDs: increased gastrointestinal ulcer risk.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may require dose adjustment for hyperglycaemia. - Antihypertensives: possible reduction in blood pressure control. - Non‑live vaccines: monitor immune response efficacy.